Literature DB >> 15178344

Insights into the specificity of RNA cleavage by the Escherichia coli MazF toxin.

Ana J Muñoz-Gómez1, Sandra Santos-Sierra, Alfredo Berzal-Herranz, Marc Lemonnier, Ramón Díaz-Orejas.   

Abstract

The mazEF (chpA) toxin-antitoxin system of Escherichia coli is involved in the cell response to nutritional and antibiotic stresses as well as in bacterial-programmed cell death. Valuable information on the MazF toxin was derived from the determination of the crystal structure of the MazE/MazF complex and from in vivo data, suggesting that MazF promoted ribosome-dependent cleavage of messenger RNA. However, it was concluded from recent in vitro analyses using a MazF-(His6) fusion protein that MazF was an endoribonuclease that cleaved messenger RNA specifically at 5'-ACA-3' sites situated in single-stranded regions. In contrast, our work reported here shows that native MazF protein cleaves RNA at the 5' side of residue A in 5'-NAC-3' sequences (where N is preferentially U or A). MazF-dependent cleavage occurred at target sequences situated either in single- or double-stranded RNA regions. These activities were neutralized by a His6-MazE antitoxin. Although essentially consistent with previous in vivo reports on the substrate specificity of MazF, our results strongly suggest that the endoribonuclease activity of MazF may be modulated by additional factors to cleave messenger and other cellular RNAs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178344     DOI: 10.1016/j.febslet.2004.05.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  40 in total

1.  Induction of Escherichia coli chromosomal mazEF by stressful conditions causes an irreversible loss of viability.

Authors:  Ilana Kolodkin-Gal; Hanna Engelberg-Kulka
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

2.  Determination of ribonuclease sequence-specificity using Pentaprobes and mass spectrometry.

Authors:  Joanna L McKenzie; Johanna M Duyvestyn; Tony Smith; Katerina Bendak; Joel Mackay; Ray Cursons; Gregory M Cook; Vickery L Arcus
Journal:  RNA       Date:  2012-04-26       Impact factor: 4.942

3.  Escherichia coli rnlA and rnlB compose a novel toxin-antitoxin system.

Authors:  Mitsunori Koga; Yuichi Otsuka; Sébastien Lemire; Tetsuro Yonesaki
Journal:  Genetics       Date:  2010-10-26       Impact factor: 4.562

4.  Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation.

Authors:  Shaleen B Korch; Thomas M Hill
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

5.  A continuous fluorometric assay for the assessment of MazF ribonuclease activity.

Authors:  Nora R Wang; Paul J Hergenrother
Journal:  Anal Biochem       Date:  2007-07-26       Impact factor: 3.365

6.  Influence of operator site geometry on transcriptional control by the YefM-YoeB toxin-antitoxin complex.

Authors:  Simon E S Bailey; Finbarr Hayes
Journal:  J Bacteriol       Date:  2008-11-21       Impact factor: 3.490

7.  Transcriptional processing of the pst operon of Escherichia coli.

Authors:  Meire Aguena; Beny Spira
Journal:  Curr Microbiol       Date:  2008-11-19       Impact factor: 2.188

Review 8.  Tumor vascular infarction: prospects and challenges.

Authors:  Rana Jahanban-Esfahlan; Khaled Seidi; Nosratollah Zarghami
Journal:  Int J Hematol       Date:  2017-01-02       Impact factor: 2.490

9.  MazF-mediated cell death in Escherichia coli: a point of no return.

Authors:  Shahar Amitai; Yussuf Yassin; Hanna Engelberg-Kulka
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

10.  Novel Escherichia coli RF1 mutants with decreased translation termination activity and increased sensitivity to the cytotoxic effect of the bacterial toxins Kid and RelE.

Authors:  Elizabeth Diago-Navarro; Liliana Mora; Richard H Buckingham; Ramón Díaz-Orejas; Marc Lemonnier
Journal:  Mol Microbiol       Date:  2008-10-28       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.